(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S.

Indictments, subpoenas, and debarments are hitting American scientists embroiled in the controversy over COVID’s origins.

Clinic apologises to affected clients and says it has set up an internal task force to conduct a review to improve procedures ...

A defense attorney sought dismissal of a firearm possession case in Kings County Criminal Court following a preliminary ...

A viral report claiming high coliform bacteria levels in popular dairy products has sparked concern. Here's what coliform ...

A preliminary report said the plane that crashed at Butler Memorial Airport had completed two earlier skydiving flights on ...

Cyclone Pods today published the complete third-party laboratory results for both of its product lines, naming the testing ...